If you have diabetes, your doctor might suggest Admelog as a treatment option for you. It’s a prescription drug used to manage blood sugar levels in: adults with type 2 diabetes adults and children ...

The cost of insulin has been a major policy issue in recent years. FDA Commissioner Scott Gottlieb, MD, said the approval of a new choice in insulin was a sign of his commitment to giving patients ...

(HealthDay)—Admelog (insulin lispro), a short-acting form of insulin, has been approved by the U.S. Food and Drug Administration to treat patients aged 3 years and older with either type of diabetes.

With an FDA nod for its copycat of Eli Lilly's popular Humalog insulin, Sanofi is one step closer to challenging blockbuster diabetes sales from its rival. Sanofi's Admelog is the first meal-time ...

The US Food and Drug Administration has cleared Sanofi's Admelog, the first follow-on biologic version of Eli Lilly’s Humalog, to manage mealtime blood sugar levels in people with diabetes. The US ...

Admelog (insulin lispro injection) 100 Units/mL will be available in U.S. in vial and SoloStar pen Paris, France - December 11, 2017 - The U.S. Food and Drug Administration (FDA) has approved Sanofi`s ...

Louisiana has garnered plenty of headlines for its new "Netflix" approach to buying hepatitis C drugs. Now, Sanofi has unveiled a program that takes that model directly to patients, supplying insulin ...

Pending any patent issues that have yet to be resolved by the Company, the FDA has concluded that the product has met all necessary regulatory requirements for approval. The Food and Drug ...

Paris, France - December 11, 2017 - The U.S. Food and Drug Administration (FDA) has approved Sanofi`s Admelog ®, the first follow-on insulin lispro to help people living with diabetes manage blood ...